Godrej & Boyce, part of over USD 4.1 billion Godrej Group and a leading maker of medical refrigerators in India, said it is quite open to collaborate with vaccine makers such as Pfizer, whose Covid vaccine is required to be kept at minus 80 degrees celsius.
When asked about a possibility of forming any partnership with Pfizer or Moderna, Godrej & Boyce Executive Director Nyrika Holkar told PTI: "As an organisation, we believe in strong partnerships and collaborations."
"Now as procurement of vaccinations has been opened up for private-sector corporations and hospitals, we are also looking at partnerships and collaborations in this regard," she added.
Godrej & Boyce, in partnership with the UK-based The Sure Chill Company, sells medical refrigerators that use the properties of water to keep vaccines in the desired temperature range.
Its step-down unit Godrej Appliances, which manufactures medical refrigerators, has Increased capacity from 10,000 units to 35,000 units and has witnessed a multi-fold growth in sales.
"For Moderna, we have already got 10,000 units on order. A part of that has already been supplied. For Pfizer which requires -86 degrees storage temperature, we are ready with our product range to need the meets of the market," said a Godrej Appliances official.
While Tata Group firm Voltas is importing specialised deep freezers that run on ultra-low temperatures and has also tied up with international partners.
"We are already in the process of importing ultra-low temperature deep freezers (-40 to -86 deg C) to meet the requirements of other vaccines like Pfizer. We are importing these specialised deep freezer models in 300 litre capacity and above, and have tied up with our international partners," said Voltas MD and CEO Pradeep Bakshi.
Voltas will be ready to cater to this requirement by the time these vaccines arrive in India by August 2021, he said. "We are also simultaneously developing specialised ice-lined refrigerator and deep freezer models for standard +ve and ve temp range."
According to Bakshi, the industry is broadly divided into three segments - below 20 degree celsius, -20 to -40 deg cel and above -40 deg cel.
The third segment is a niche, and as of now, the industry is importing this segment, he added.
For the current vaccination drive of the government, related to Covaxin, Covishield and Sputnik, Voltas has a range of solutions to serve different requirements.
Blue Star Managing Director B Thiagarajan said the segment is very small and the demand is only for a very brief period.
There are three elements in this business primary cold storage at the main distribution centres, freezers at the intermediate centres and vaccine transporters.
The volume is so small that a 400 litres freezer can have a storage of 76,000 doses of vaccines and simple one thousand sq feet cold room could store over 1.45 lakh doses.
"Required volume is not that much. The demand would come and soon go away. The incremental market size of vaccination storage is also not very big, its juts around Rs 250 crore," he said adding that most of the order from the government and some from private hospitals has been finalised.
Now Pfizer and Moderna are coming, which require storage at minus 80-degree temperature but he is not sure about the volume of purchase.
"We are selling refrigerators with up to -80 degree celsius, we have some orders. Around 600 freezers would be sold, Thiagarajan said adding that "people think it is a big opportunity. It is just Rs 250 crore market.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.